Vaneck Vectors Pharmaceutical etf shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $0 | 257k | 0.00 |
| 2025-03-31 | $0 | 8.7k | 0.00 |
| 2024-12-31 | $976k | 11k | 86.28 |
| 2024-09-30 | $907k | 9.5k | 95.03 |
| 2024-06-30 | $14M | 156k | 91.48 |
| 2024-03-31 | $9.7M | 107k | 90.70 |
| 2023-12-31 | $13M | 158k | 81.37 |
| 2023-09-30 | $16M | 203k | 79.86 |
| 2023-06-30 | $4.2M | 53k | 78.77 |
| 2023-03-31 | $4.0M | 51k | 77.64 |
| 2022-12-31 | $46k | 588 | 78.23 |
| 2019-09-30 | $5.7M | 101k | 56.89 |
| 2019-06-30 | $51k | 880 | 57.95 |
| 2019-03-31 | $53k | 880 | 60.23 |
| 2018-12-31 | $98k | 1.8k | 54.84 |
| 2018-09-30 | $120k | 1.9k | 64.21 |
| 2018-06-30 | $115k | 1.9k | 59.00 |
| 2018-03-31 | $111k | 1.9k | 56.95 |
| 2017-12-31 | $116k | 1.9k | 59.52 |
| 2017-06-30 | $136k | 2.3k | 59.16 |
| 2017-03-31 | $124k | 2.2k | 55.14 |
| 2016-12-31 | $13M | 252k | 52.51 |
| 2016-09-30 | $133k | 2.3k | 57.68 |
| 2016-06-30 | $175k | 3.0k | 58.45 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf